Your opportunity to connect directly with the virology sector
If you would like us to create a package aligned to your marketing needs, please contact Kim kim@laevents.com.au | 61 3 6234 7844
Our Sponsors
Major Sponsor
Seqirus has public health protection at its core, reflecting the promise of our parent company – CSL Limited – which was founded in 1916 to save lives and protect the health of people. Together with our partners on the front line, we have served Australia’s healthcare needs for over a century. Today we develop, manufacture and source medicines that support the health and well-being of many thousands of people around the world. Seqirus operates Australia’s only local manufacturing facility for seasonal and pandemic influenza vaccine, and produces a range of unique medicines in the national interest including antivenoms and Q fever vaccine. Seqirus also in-licenses a broad range of paediatric and adult vaccines and specialty pharmaceutical products.
Welcome Mixer Sponsor
Poster Session Sponsors
Comprising over 200 researchers, students and support staff, the Institute for Glycomics strives to be a world leader in the discovery and development of next generation drugs, vaccines and diagnostics for diseases of global impact.
Established in 2000, the Institute for Glycomics is one of Australia’s flagship interdisciplinary translational biomedical research institutes, based at Griffith University’s Gold Coast campus. The Institute’s research primarily targets identification, prevention and cures for cancers, infectious diseases, and neurodegenerative disorders.
The needle-free future of vaccination.
An advanced platform that vaccinates by applying a patch to the skin for a few seconds. Engineered to directly deposit vaccine amongst dense population of key immune cells in the skin, developing an efficient and effective immune response.
Engineered to be better.
Better scientifically. Better for patients. Better for safety.
Electronic Handbook & Program Sponsor
Eppendorf is a leading life science company that develops and supplies innovative solutions for liquid-, sample-, and cell handling in laboratories worldwide. Our products include pipettes and automated pipetting systems, centrifuges, thermal cyclers, ULT freezers, CO2 incubators and shakers as well as premium pipette tips, Eppendorf tubes and plates. We’re committed to providing reliable services and tools to support your applications and help you maintain premium performance and longevity of our systems.
Visit Eppendorf’s website: www.eppendorf.com.au
Session Sponsor – Antivirals and Vaccines
Burnet Institute is an Australian, independent, not-for-profit organisation. Its mission is to achieve better health for vulnerable communities by accelerating the translation of research, discovery and evidence into sustainable health solutions. Burnet brings together a highly diverse skill base of medical researchers, public health and international development professionals with a key focus on Infectious Disease Elimination, Maternal, Child and Adolescent Health, Behaviours and Health Risks, and Health Security.
Session Sponsor – Indigenous Virology
Finding solutions to prevent, treat and cure infectious diseases and understanding the complexities of microbes and the immune system requires innovative approaches and concentrated effort. This is why The University of Melbourne – a world leader in education, teaching and research excellence – and The Royal Melbourne Hospital – an internationally renowned institution providing outstanding care, research and learning – have partnered to create the Peter Doherty Institute for Infection and Immunity (Doherty Institute); a centre of excellence where leading scientists and clinicians collaborate to improve human health globally.
Travel Award Sponsor
Finding solutions to prevent, treat and cure infectious diseases and understanding the complexities of microbes and the immune system requires innovative approaches and concentrated effort. This is why The University of Melbourne – a world leader in education, teaching and research excellence – and The Royal Melbourne Hospital – an internationally renowned institution providing outstanding care, research and learning – have partnered to create the Peter Doherty Institute for Infection and Immunity (Doherty Institute); a centre of excellence where leading scientists and clinicians collaborate to improve human health globally.
www.biomedicalsciences.unimelb.edu.au/departments/microbiology-immunology
Finding solutions to prevent, treat and cure infectious diseases and understanding the complexities of microbes and the immune system requires innovative approaches and concentrated effort. This is why The University of Melbourne – a world leader in education, teaching and research excellence – and The Royal Melbourne Hospital – an internationally renowned institution providing outstanding care, research and learning – have partnered to create the Peter Doherty Institute for Infection and Immunity (Doherty Institute); a centre of excellence where leading scientists and clinicians collaborate to improve human health globally.
Destination Partner
Our Exhibitors
Eppendorf is a leading life science company that develops and supplies innovative solutions for liquid-, sample-, and cell handling in laboratories worldwide. Our products include pipettes and automated pipetting systems, centrifuges, thermal cyclers, ULT freezers, CO2 incubators and shakers as well as premium pipette tips, Eppendorf tubes and plates. We’re committed to providing reliable services and tools to support your applications and help you maintain premium performance and longevity of our systems.
Visit Eppendorf’s website: www.eppendorf.com.au
Comprising over 200 researchers, students and support staff, the Institute for Glycomics strives to be a world leader in the discovery and development of next generation drugs, vaccines and diagnostics for diseases of global impact.
Established in 2000, the Institute for Glycomics is one of Australia’s flagship interdisciplinary translational biomedical research institutes, based at Griffith University’s Gold Coast campus. The Institute’s research primarily targets identification, prevention and cures for cancers, infectious diseases, and neurodegenerative disorders.
Seqirus has public health protection at its core, reflecting the promise of our parent company – CSL Limited – which was founded in 1916 to save lives and protect the health of people. Together with our partners on the front line, we have served Australia’s healthcare needs for over a century. Today we develop, manufacture and source medicines that support the health and well-being of many thousands of people around the world. Seqirus operates Australia’s only local manufacturing facility for seasonal and pandemic influenza vaccine, and produces a range of unique medicines in the national interest including antivenoms and Q fever vaccine. Seqirus also in-licenses a broad range of paediatric and adult vaccines and specialty pharmaceutical products.
The needle-free future of vaccination.
An advanced platform that vaccinates by applying a patch to the skin for a few seconds. Engineered to directly deposit vaccine amongst dense population of key immune cells in the skin, developing an efficient and effective immune response.
Engineered to be better.
Better scientifically. Better for patients. Better for safety.